Ticker
TSHACompany Name
TAYSHA GENE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 793.83M | $ 222.61M | $ 0 | $ 0 | -28.04% |
3/31/2025 | $ 549.53M | $ 76.92M | $ 0 | $ 0 | -14% |
12/31/2024 | $ 332.1M | $ 76.87M | $ -18K | $ 0 | -23.14% |
9/30/2024 | $ 452.92M | $ 76.81M | $ -3.87M | $ 0 | -16.1% |
6/30/2024 | $ 418.08M | $ 210.81M | $ -3.87M | $ 0 | -49.5% |
3/31/2024 | $ 480.64M | $ 140.83M | $ -3.87M | $ 0 | -28.5% |
12/31/2023 | $ 420.79M | $ 140.86M | $ -3.85M | $ 0 | -32.56% |
9/30/2023 | $ 248.66M | $ 182.88M | $ 0 | $ 0 | -73.55% |
6/30/2023 | $ 137.31M | $ 42.09M | $ 0 | $ 0 | -30.65% |
3/31/2023 | $ 45.5M | $ 53.27M | $ 0 | $ 0 | -117.07% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for TAYSHA GENE THERAPIES INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 759M ]
(=) Shareholder Yield [ 0% ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |